Minimum clinically important difference in Quantitative Lung Fibrosis score associated with all-cause mortality in idiopathic pulmonary fibrosis: subanalysis from two phase II trials of pamrevlumab

By sjmartinez • May 13, 2025

Kim GH, Zhang X, Brown MS, Poole L, Goldin J. Minimum clinically important difference in Quantitative Lung Fibrosis score associated with all-cause mortality in idiopathic pulmonary fibrosis: subanalysis from two phase II trials of pamrevlumab. BMJ Open. 2025 May 12;15(5):e094559. doi: 10.1136/bmjopen-2024-094559. PMID: 40355288.

Tags: Chest imaging, Computed tomography, interstitial lung disease, Patient reported outcome measures, Publications, Pulmonary Disease, Pulmonary, Critical Care & Sleep Medicine, QUALITATIVE RESEARCH

Delayed diagnosis of pemphigus herpetiformis in a patient with dupilumab-associated hypereosinophilia

Smith SE, Swanson LA, Wonnaparhown A, DiCaudo DJ, Nelson SA, Kasperkiewicz M. Delayed diagnosis of pemphigus herpetiformis in a patient with dupilumab-associated hypereosinophilia. JAAD Case[...]

Managing Rosacea with Nanodiamond-zinc Oxide: Real-world Evidence for Reduction in Redness and Acne Lesions

Zhang XD, Bai XS, Teng C, Chilukuri S, Teng J, Ablon G, Gold MH. Managing Rosacea with Nanodiamond-zinc Oxide: Real-world Evidence for Reduction in Redness[...]

COVID-19 Pandemic-Related Disruptions in Routine Cirrhosis Care and Associated Clinical Outcomes among San Francisco Bay Area Veterans

Rubin JB, Loeb R, Monto A, Wong RJ, Cheung R, Batki SL, Ostacher MJ, Shen H, Hoggatt KJ, Satre DD, Khalili M. COVID-19 Pandemic-Related Disruptions[...]